Sign up to save your podcasts
Or
Share Episode 8: FDA Changes to the CAR-T Monitoring Program
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 8: FDA Changes to the CAR-T Monitoring Program
Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.
View all episodes
By Chadi NabhanDr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.